Summary
Gilead Sciences, Inc. (GILD) filed an 8-K report on July 25, 2013, to announce its financial results for the second quarter ended June 30, 2013. The report primarily references a press release (Exhibit 99.1) which contains detailed financial information. Investors should note that Gilead presented both GAAP and non-GAAP financial measures, with management believing the non-GAAP figures offer additional insights useful for operational and financial planning. While the 8-K itself does not provide the specific financial figures, it directs investors to the accompanying press release for comprehensive details. This filing serves as a notification of the release of these results and offers a supplemental view of the company's performance through non-GAAP metrics, which are reconciled with GAAP figures in the press release. Investors are encouraged to review the press release for a full understanding of Gilead's financial condition and results of operations for the period.
Key Highlights
- 1Gilead Sciences announced its Q2 2013 financial results via an 8-K filing on July 25, 2013.
- 2The filing references a press release (Exhibit 99.1) for detailed financial information.
- 3Gilead presented financial results on both a GAAP and a non-GAAP basis.
- 4Management believes non-GAAP measures provide useful insights for investors.
- 5Non-GAAP information is used internally for operational, budgeting, and financial planning.
- 6Reconciliation between GAAP and non-GAAP figures is available in the press release.
- 7The information is furnished, not filed, under Section 18 of the Exchange Act.